Q-linea AB (publ)

kr 13.50As of Sun 8 Nov 2026, 12:00 UTC
STO:QLINEAHealthcare
Country Sweden
PE (Fwd) •••
TSR 8Y CAGR (65.41%)
Div yield —
ROE (84.02%)
Medical Devices
Beta (5Y) 0.50
PE TTM —
TSR TTM (46.10%)
Mkt cap kr 255.8M
ROIC (44.93%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 14
5.41%
(24.08%)
Hold 0|12|5|12|10
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.16
0.17
0.17
0.16
20.17%
27.22%
12.18%
3.89%
Revenuekr M
11.25
11.34
11.51
11.55
2.14%
5.22%
4.11%
3.52%
Peers (US$25.86M)
Cap (US$)
PE
21.76M
—
20.82M
—
Capital
TTM
5Y
10Y
Leveragex
1.397
0.330
0.331
EBIT/Intx
1.081
0.622
0.622
Own earn%
57.20
(220.25)
(169.16)
Sh yield%
35.37
8.21
8.38
Owners
Insiders/Inst%
6.39
42.11
Short interest%
3.91
SBC / revenue%
4.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
29–31
$1 testx
0.2
Incr. ROIC%
−2